Effect of N-Acetylcysteine on Residual Renal Function in Chronic Haemodialysis Patients Treated with High-Flux Synthetic Dialysis Membranes: A Pilot Study
ISRN Nephrology · 2013
DOI: 10.5402/2013/636208 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN Nephrology, 2013. Verfasst von Leonid Feldman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Division and Research & Development Unit, Assaf Harofeh Medical Center, Zerifin 70300, Israel ; Sackler Faculty of Medicine, Tel Aviv Univ…. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Teva Pharmaceutical Industries.
Abstract (Originalsprache)
Background
Preservation of residual renal function in chronic dialysis patients has proven to be a major predictor of survival. The aim of the present study was to investigate an ability of the combined use of N-acetylcysteine and high-flux biocompatible haemodialysis membranes to improve residual renal function in haemodialysis patients. Patients and Methods . Chronic haemodialysis patients with a residual urine output of at least 100 mL/24 h were administered oral an N-acetylcysteine 1200 mg twice daily for 2 weeks. Treatment group included patients treated with dialysers using high-flux synthetic biocompatible membranes. Control group included patients treated with dialysers using low-flux semisyntetic triacetate haemodialysis membranes.
Results
Eighteen patients participated in the study. The residual glomerular filtration rate showed a nonsignificant trend for increase in both groups. The magnitude of GFR improvement after N-acetylcysteine administration was less pronounced in the group treated with high-flux biocompatible membranes: +0.17 ± 0.56 mL/min/1.73 m 2 in treatment group and +0.65 ± 0.53 mL/min/1.73 m 2 in control group ( P < 0.05 ).
Conclusion
In this study of favorable effect of N-acetylcysteine on residual renal function in chronic haemodialysis patients may be less pronounced when using high-flux biocompatible, rather than low-flux semisyntetic, HD membranes.
Autor:innen und Institutionen
- Nephrology Division and Research & Development Unit, Assaf Harofeh Medical Center, Zerifin 70300, Israel ; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
- Nephrology Division and Research & Development Unit, Assaf Harofeh Medical Center, Zerifin 70300, Israel.
- Family Medicine Department, Clalit Health Services and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 97904, Israel.
Förderung
- Teva Pharmaceutical Industries
Zitieren
APA
Feldman, L., Abu Hamad, R., Efrati, S., Ashker, A., Beberashvili, I., & Shani, M. (2013). Effect of N-Acetylcysteine on Residual Renal Function in Chronic Haemodialysis Patients Treated with High-Flux Synthetic Dialysis Membranes: A Pilot Study. ISRN Nephrology. https://doi.org/10.5402/2013/636208
Vancouver
Feldman L, Abu Hamad R, Efrati S, Ashker A, Beberashvili I, Shani M. Effect of N-Acetylcysteine on Residual Renal Function in Chronic Haemodialysis Patients Treated with High-Flux Synthetic Dialysis Membranes: A Pilot Study. ISRN Nephrology. 2013. doi:10.5402/2013/636208
BibTeX
@article{Feldman2013,
author = {Feldman, Leonid and Abu Hamad, Ramzia and Efrati, Shai and Ashker, Ali and Beberashvili, Ilia and Shani, Michal},
title = {Effect of N-Acetylcysteine on Residual Renal Function in Chronic Haemodialysis Patients Treated with High-Flux Synthetic Dialysis Membranes: A Pilot Study},
journal = {ISRN Nephrology},
year = {2013},
doi = {10.5402/2013/636208}
}
EUVIMED